NASDAQ:SMED - Nasdaq - US8200171010 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 44.31M 10.39% | 51.15M 15.44% | 76.424M 49.41% | 66.742M -12.67% | 68.714M 2.95% | 77.367M 12.59% | 81.746M 5.66% | 88.101M 7.77% | |
EBITDA YoY % growth | 2.11M 115.31% | 2.52M 19.43% | 14.291M 467.10% | 2.412M -83.12% | 4.964M 105.78% | 8.466M 70.55% | 15.618M 84.47% | 29.387M 88.16% | |
EBIT YoY % growth | 450K 177.59% | 910K 102.22% | 12.302M 1,251.87% | -153K -101.24% | 2.448M 1,700.00% | 7.038M 187.50% | 17.25M 145.10% | 43.125M 150.00% | |
Operating Margin | 1.02% | 1.78% | 16.10% | -0.23% | 3.56% | 9.10% | 21.10% | 48.95% | |
EPS YoY % growth | 0.01 120.00% | 0.13 1,200.00% | 0.62 376.92% | 0.02 -96.71% | 0.09 325.00% | 0.27 205.88% | 0.65 145.10% | 1.63 150.00% |
Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | |
---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 0.04 -76.00% | -0.02 49.00% | 0.00 -100.00% | 0.08 916.00% | 0.10 150.00% | 0.02 200.00% | 0.06 |
Revenue Q2Q % growth | 18.666M -0.36% | 16.014M 15.08% | 15.81M -51.79% | 19.38M 10.25% | 21.318M 14.21% | 18.972M 18.47% | 18.768M 18.71% |
EBITDA Q2Q % growth | 1.734M -56.45% | 102K 108.97% | 714K 183.33% | N/A | N/A | N/A | N/A |
EBIT Q2Q % growth | 1.122M -43.70% | -510K 70.33% | 102K 111.16% | N/A | N/A | N/A | N/A |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q3 2022 Q2Q % growth | -0.01 -102.50% | 0.02 | -0.03 | -149.02% |
Q2 2022 Q2Q % growth | 0.07 | 0.00 | 0.07 | 1,369.54% |
Q1 2022 Q2Q % growth | -0.04 -100.00% | 0.04 | -0.08 | -204.58% |
Q4 2021 Q2Q % growth | 0.17 30.77% | 0.07 | 0.10 | 145.82% |
Q3 2021 Q2Q % growth | 0.40 500.00% | -0.03 | 0.43 | 1,608.30% |
Q2 2021 Q2Q % growth | 0.07 16.67% | 0.20 | -0.13 | -65.69% |
Q1 2021 Q2Q % growth | -0.02 -150.00% | 0.14 | -0.16 | -114.76% |
Q4 2020 Q2Q % growth | 0.13 333.33% | 0.07 | 0.06 | 88.82% |
Q3 2020 Q2Q % growth | -0.10 -42.86% | 0.04 | -0.14 | -330.68% |
Q2 2020 Q2Q % growth | 0.06 20.00% | 0.01 | 0.05 | 684.31% |
Q1 2020 Q2Q % growth | 0.04 | -0.05 | 0.09 | 188.46% |
Q4 2019 Q2Q % growth | 0.03 | 0.03 | 0.00 | 10.28% |
Q3 2019 Q2Q % growth | -0.07 | 0.01 | -0.08 | -786.27% |
Q2 2019 Q2Q % growth | 0.05 | 0.01 | 0.04 | 634.93% |
Q1 2019 Q2Q % growth | 0.00 | -0.01 | 0.01 | 100.00% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q3 2022 Q2Q % growth | 17.579M -36.15% | 16.626M | 953K | 5.73% |
Q2 2022 Q2Q % growth | 32.793M 92.79% | 15.429M | 17.364M | 112.54% |
Q1 2022 Q2Q % growth | 13.915M 5.82% | 16.882M | -2.967M | -17.57% |
Q4 2021 Q2Q % growth | 18.734M 49.04% | 18.352M | 381.752K | 2.08% |
Q3 2021 Q2Q % growth | 27.53M 164.46% | 13.657M | 13.873M | 101.59% |
Q2 2021 Q2Q % growth | 17.01M 16.75% | 24.015M | -7.005M | -29.17% |
Q1 2021 Q2Q % growth | 13.15M -3.31% | 22.075M | -8.925M | -40.43% |
Q4 2020 Q2Q % growth | 12.57M 3.29% | 16.453M | -3.883M | -23.60% |
Q3 2020 Q2Q % growth | 10.41M 10.16% | 15.284M | -4.874M | -31.89% |
Q2 2020 Q2Q % growth | 14.57M 17.59% | 13.003M | 1.567M | 12.05% |
Q1 2020 Q2Q % growth | 13.6M 32.17% | 10.849M | 2.751M | 25.35% |
Q4 2019 Q2Q % growth | 12.17M | 12.35M | -180.16K | -1.46% |
Q3 2019 Q2Q % growth | 9.45M | 11.571M | -2.121M | -18.33% |
Q2 2019 Q2Q % growth | 12.39M | 10.988M | 1.402M | 12.76% |
Q1 2019 Q2Q % growth | 10.29M | 10.29M | 240 | 0.00% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | N/A | N/A | N/A | N/A |
Revenue | N/A | N/A | N/A | N/A |